Urinary oestrogen excretion after metyrapone administration to patients with the polycystic ovary syndrome.
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000568:Amenorrhea / Q000652:urine*; D003907:Dexamethasone; D004958:Estradiol / Q000652:urine*; D004964:Estriol / Q000652:urine*; D004970:Estrone / Q000652:urine*; D005246:Feedback; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D008797:Metyrapone / Q000494:pharmacology*; D008875:Middle Aged; D010048:Ovarian Cysts / Q000652:urine*; D010913:Pituitary-Adrenal System; D011085:Polycystic Ovary Syndrome / Q000652:urine*
D015068:17-Ketosteroids; D004970:Estrone; D004958:Estradiol; D003907:Dexamethasone; D004964:Estriol; D008797:Metyrapone